Technology
Health
Pharmaceutical

Eyegate Pharmaceuticals

$0.2245
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0015 (-0.66%) Today
$0.00 (0.00%) As of 3:59 PM EDT after-hours

Why Robinhood?

You can buy or sell EYEG and other stocks, options, ETFs, and crypto commission-free!

About EYEG

Eyegate Pharmaceuticals, Inc. Common Stock, also called Eyegate Pharmaceuticals, is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Read More Its pipeline includes EGP-437 and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.

Employees
11
Headquarters
Waltham, Massachusetts
Founded
1998
Market Cap
10.34M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
402.79K
High Today
$0.2367
Low Today
$0.22
Open Price
$0.234
Volume
282.42K
52 Week High
$0.86
52 Week Low
$0.21

Collections

Technology
Health
Pharmaceutical
Medical
2015 IPO
US
North America

EYEG Earnings

-$0.24
-$0.16
-$0.07
$0.01
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 2, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.